GENEVA, July 8 -- CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD. (No. 263, Hexiang 3rd Street, High-tech Zone,Chengdu, Sichuan 610094), 成都倍特药业股份有限公司 (中国四川省成都市高新区和祥三街263号) filed a patent application (PCT/CN2024/142822) for "LIVER-TARGETING COMPOUND AND USE THEREOF IN DRUG CONJUGATE" on Dec 26, 2024. With publication no. WO/2025/140434, the details related to the patent application was published on Jul 03, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intelle...